Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[90Y]Y-PentixaTher in Recurrent or Refractory CNS Lymphoma
NCT06132737Phase 2Recruiting
- Sponsor
- Pentixapharm
- Start
- Nov 2023
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 90Y-Pentixather in central nervous system lymphoma, sponsored by Pentixapharm. Started Nov 2023; status: recruiting.
02
Drugs
90Y-Pentixather
03
Conditions
central nervous system lymphoma
Beyond the preview
Go deeper on NCT06132737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06132737.